$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Method for stabilising an immunoglobulin G composition in liquid form 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-039/395
출원번호 US-0752189 (2013-01-28)
등록번호 US-9463241 (2016-10-11)
우선권정보 FR-03 04388 (2003-04-09)
발명자 / 주소
  • Bardat, Annie
  • Begin, Edith
  • Khandoudi, Nassirah
  • Just, Olivier
  • Chtourou, Sami
  • Schmitthaeusler, Roland
출원인 / 주소
  • LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
대리인 / 주소
    Birch, Stewart, Kolasch & Birch, LLP
인용정보 피인용 횟수 : 0  인용 특허 : 46

초록

This invention is related to a stabilizing formulation for immunoglobulins G compositions comprising a sugar alcohol, glycine and a non-ionic detergent, which is suitable for the stabilization of immunoglobulins G compositions in liquid form and in lyophilized form. The invention also relates to an

대표청구항

1. A method of stabilising a polyclonal immunoglobulin G composition in liquid form obtained directly by fractioning of human plasma, said method comprising combining said polyclonal immunoglobulin G (IgG) composition with a stabilising formulation for IgG compositions, wherein the formulation consi

이 특허에 인용된 특허 (46) 인용/피인용 타임라인 분석

  1. Slavin Shimon,ILX, Allogeneic cell therapy for cancer following allogeneic stem cell transplantation.
  2. Rubenstein Kenneth Edward (Palo Alto CA) Leute Richard K. (Sunnyvale CA), Antibody steric hindrance immunoassay with two antibodies.
  3. Frossard Philippe M. (Palo Alto CA), Apo AI/CIII genomic polymorphisms predictive of atherosclerosis.
  4. Baumann Matthias,DEX ; Ochlich Peter-Paul,DEX, Combination of G-CSF with a chemotherapeutic agent for stem cell mobilization.
  5. Atkinson, Brent; Benedict, James J., Compositions for regeneration and repair of cartilage lesions.
  6. Mark David F. (Danville CA) Lin Leo S. (Fremont CA) Yu Lu Shi-da (Oakland CA) Wang Alice M. (Walnut Creek CA), Cysteine-depleted muteins of biologically active proteins.
  7. Uzgiris Egidijus E. (Schenectady NY), Electrophoretic method of detecting antigen-antibody reaction.
  8. Ullman Edwin F. (Atherton CA) Schwarzberg Moshe (Palo Alto CA), Fluorescence quenching with immunological pairs in immunoassays.
  9. Kaufman Dan S. ; Thomson James A., Hematopoietic differentiation of human pluripotent embryonic stem cells.
  10. Comoglio Paolo,ITX, Hepatocyte growth factor--induced proliferation and differentiation of erythroid cells.
  11. Zolton Raymond P. (Somerville NJ) Nasser Jennifer A. (Piscataway NJ), Histidine stabilized immunoglobulin and method of preparation.
  12. Gearhart John D. ; Shamblott Michael Joseph, Human embryonic pluripotent germ cells.
  13. Caplan Arnold I. (Cleveland Heights OH) Haynesworth Stephen E. (Cleveland Heights OH), Human mesenchymal stem cells.
  14. Penelope E. Roberts ; Jennie Powell Mather, Human pancreatic epithelial progenitor cells and methods of isolation and use thereof.
  15. Mark David F. (Plainsboro NJ) Lin Leo S. (Walnut Creek CA) Lu Shi-da Y. (Cupertino CA), Human recombinant interleukin-2 muteins.
  16. Wands Jack R. (Waban MA) Zurawski ; Jr. Vincent R. (West Chester PA) Schoemaker ; Hubert J. P. (Newton MA), Immunoassay utilizing monoclonal high affinity IgM antibodies.
  17. Ford, John; Ho, Alice Suk-Yue; Pace, Ann, Interleukin--1 receptor antagonist and uses thereof.
  18. Namen Anthony E. (Seattle ; WA) Goodwin Raymond G. (Seattle ; WA) Lupton Stephen D. (Seattle ; WA) Mochizuki Diane Y. (Seattle ; WA), Interleukin-7.
  19. Simons Malcolm J. (Fryerstown AUX), Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes.
  20. Meade Harry (Newton MA) Lonberg Nils (New York NY), Isolation of exogenous recombinant proteins from the milk of transgenic mammals.
  21. Grompe Markus, Liver regeneration using pancreas cells.
  22. Zaner Leonard A. (1300 Jerry St. Madison Heights MI 48071), Longitudinally extensible stringer and stairway.
  23. Lee Frank (Palo Alto CA) Yokota Takashi (Palo Alto CA) Arai Ken-ichi (Palo Alto CA) Mosmann Timothy (Atherton CA) Rennick Donna (Los Altos CA), Mammalian interleukin-4.
  24. Rodgers Kathleen E. ; DiZerega Gere, Method for promoting mesenchymal stem and lineage-specific cell proliferation.
  25. Susumu Ikehara JP; Muneo Inaba JP; Kenji Takeuchi JP; Taketoshi Kushida JP, Method for transplantation of hemopoietic stem cells.
  26. Smulson Mark E. (Washington DC) Bhatia Kishor (Arbutus MD) Huppi Konrad (Reston VA), Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for hu.
  27. Louis Martin Pelus ; Andrew Garrison King ; Yanqiu Qian, Method of mobilizing hematopoietic stem cells.
  28. Emerson Stephen G. ; Clarke Michael F. ; Palsson Bernhard O., Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 sec.
  29. Uchida Nobuko ; Tsukamoto Ann ; Weissman Irving, Methods for gene transfer.
  30. Csete Marie ; Doyle John ; Wold Barbara, Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells.
  31. Trojanowski John Q. (Philadelphia PA) Lee Virginia M-Y. (Philadelphia PA), Modified avidin-biotin technique.
  32. Bellet Dominique (Paris MA FRX) Wands Jack R. (Waban MA), Multiepitopic immunometric assay.
  33. Koths Kirston E. (El Cerrito CA) Halenbeck Robert F. (San Rafael CA) Mark David F. (Plainsboro NJ) Nitecti Danutee (Berkeley CA), Oxidation-resistant muteins of Il-2 and other protein.
  34. Thomson James A., Primate embryonic stem cells.
  35. Mullis Kary B. (Kensington CA), Process for amplifying nucleic acid sequences.
  36. Andya James ; Cleland Jeffrey L. ; Hsu Chung C. ; Lam Xanthe M. ; Overcashier David E. ; Shire Steven J. ; Yang Janet Yu-Feng ; Wu Sylvia Sau-Yan, Protein formulation.
  37. Piasio ; Roger N. ; Ryan ; James W. ; Woiszwillo ; James E., Reverse sandwich immunoassay.
  38. Shaw Gray (Bedford MA), Site-specific homogeneous modification of polypeptides.
  39. Sarno Maria Erlinda C. ; Vasquez Rodolfo Anthony ; Yung Sau-Gee ; Graf Clifford R., Stable intravenously-administrable immune globulin preparation.
  40. Bachovchin William ; Wallner Barbara, Stimulation of hematopoietic cells in vitro.
  41. Mark David F. (Hercules CA) Lin Leo S. (Fremont CA) Yu Lu Shi-Da (Oakland CA), Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon- 상세보기
  • Gusella James F. (Framingham MA), Test for Huntington\s disease.
  • Gerson Stanton L. (Pepper Pike OH) Caplan Arnold I. (Cleveland Heights OH) Haynesworth Stephen E. (Cleveland Heights OH), Transduced mesenchymal stem cells.
  • Chong Kong-Teck (Union City CA), Treatment of infections with lymphokines.
  • Miles Laughton E. M. (Stanford CA), Universal reagent 2-site immunoradiometric assay using labelled anti (IgG).
  • David A. Horwitz, Use of cytokines and mitogens to inhibit graft versus host disease.
  • 활용도 분석정보

    상세보기
    다운로드
    내보내기

    활용도 Top5 특허

    해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
    더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

    섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로